GREY:TSTIF - Post by User
Comment by
Darrow100on Jan 31, 2018 8:59am
246 Views
Post# 27469098
RE:RE:Selling
RE:RE:SellingA combination of a less than concise NR by RR and the fact that TOS has put Getinge, their internationally recognized partner in the health care field, on notice due to their less than stellar preformance.
Add to that the fact that anylists, as usual, instead of taking an indepth look at the situation in a knee jerk reaction came out with a rather severe downgrade after the fact, as usual, and given that 'the market' does not like uncertainty most everyone, as usual again, overreacted.
The facts are that the VP4 was last week, is this week, and will be going forward top of the class in the low temp sterilization field and what has changed is not reality but preception
TSO3's VP4 is and will be the go to system going forward and I for one am going to wait for the FDA approval for duodenoscopes and the payoff that may have been postponed for a few more months regardless of what the 'chicken little' anylists say